TriSalus Life Sciences, Inc. ($TLSI)
Filing Information
| Accession Number | 0001628280-26-020188 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
3,457
Total Value
$14,209.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Mar 11, 2026 | Sale | 1,449 | $4.13 | $5,984.37 | 112,405 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 12, 2026 | Sale | 1,589 | $4.09 | $6,499.01 | 110,816 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 16, 2026 | Sale | 419 | $4.12 | $1,726.28 | 110,397 | Direct | โ | View Details |